1-4 of 4
André Goy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Results From a Phase 1 Multicenter Trial of Alisertib (MLN8237)–An Investigational Aurora A Kinase Inhibitor–in Patients with Advanced Hematologic Malignancies

Kevin R. Kelly, MD, Swaminathan Padmanabhan, MBBS, MD, André Goy, MD, Jesus G. Berdeja, MD, Craig B. Reeder, MD, Kevin T. McDonagh, MD, Xiaofei Zhou, PhD, Hadi Danaee, SD, Hugh Xiao, PhD, Ely Benaim, MD, Thomas C. Shea, MD
Journal: Blood
Blood (2011) 118 (21): 2477.
https://doi.org/10.1182/blood.V118.21.2477.2477
Published: 2011
Journal Articles

Bortezomib Plus Rituximab in Patients with Indolent Non-Hodgkin’s Lymphoma (NHL): A Phase 2 Study.

Sven de Vos, Shaker Dakhil, Peter McLaughlin, Mansoor Saleh, Robert Belt, Christopher Flowers, Mark Knapp, Lowell Hart, Dipti Patel-Donnelly, Martha Glenn, Stephanie A. Gregory, Charles Holladay, Anthony Boral, Tracy Zhang, André Goy
Journal: Blood
Blood (2005) 106 (11): 17.
https://doi.org/10.1182/blood.V106.11.17.17
Published: 2005
Journal Articles

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease

Clinical Trials & Observations
David J. Straus, Carol S. Portlock, Jing Qin, Jane Myers, Andrew D. Zelenetz, Craig Moskowitz, Ariela Noy, André Goy, Joachim Yahalom
Journal: Blood
Blood (2004) 104 (12): 3483–3489.
https://doi.org/10.1182/blood-2004-04-1311
Published: 2004
Journal Articles

MUC1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma

Frédéric Gilles, André Goy, Yvonne Remache, Peter Shue, Andrew D. Zelenetz
Journal: Blood
Blood (2000) 95 (9): 2930–2936.
https://doi.org/10.1182/blood.V95.9.2930.009k39_2930_2936
Published: 2000